Tracking <i>clusterin</i> expression in hematopoietic stem cells reveals their heterogeneous composition across the life span

Hematopoietic stem cells (HSCs) exhibit significant age-related phenotypic and functional alterations. Although single-cell technologies have elucidated age-related compositional changes, prospective identification of aging-associated HSC subsets has remained challenging. In this study, using clusterin (Clu)-green fluorescent protein (GFP) reporter mice, we demonstrated that Clu expression faithfully marks age-associated myeloid/platelet-biased HSCs throughout life. Clu-GFP expression clearly segregates a novel age-associated HSC subset that overlaps with but is distinct from those previously identified using antibodies against aging maker proteins or reporter systems of aged HSC signature genes. Clu-positive (Clu+) HSCs emerge as a minor population in the fetus and progressively expand with age. Clu+ HSCs display not only an increased propensity for myeloid/platelet-biased differentiation but also a unique behavior in the bone marrow, favoring self-renewal over differentiation into downstream progenitors. In contrast, Clu-negative (Clu-) HSCs exhibit lineage-balanced differentiation, which predominates in the HSC pool during development but becomes underrepresented as aging progresses. Both subsets maintain long-term self-renewal capabilities even in aged mice but contribute differently to hematopoiesis. The predominant expansion of Clu+ HSCs largely drives the age-related changes observed in the HSC pool. Conversely, Clu- HSCs preserve youthful functionality and molecular characteristics into old age. Consequently, progressive changes in the balance between Clu+ and Clu- HSC subsets account for HSC aging. Our findings establish Clu as a novel marker for identifying aging-associated changes in HSCs and provide a new approach that enables lifelong tracking of the HSC aging process.

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-03-26
DOI
https://doi.org/10.1182/blood.2024025776
Citations
6
Primary Topic
Clusterin in disease pathology
Type
article
Field-Weighted Citation Impact
6.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span

Yaeko Nakajima-Takagi, Bahityar Rahmutulla, Masayuki Yamashita, Kazuaki Yokoyama et al.
6 citations
Blood
Clusterin in disease pathology
6.27
article

Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span

Yaeko Nakajima-Takagi, Bahityar Rahmutulla, Masayuki Yamashita, Kazuaki Yokoyama, Ola Rizq, Atsushi Iwama, Claus Nerlov, Fumihito Miura, N Yusa, Akira Nishiyama, Zhiqian Zheng, Yuta Yamada, Takashi Ito, Takahiro Kamiya, Shuhei Koide, Atsushi Kaneda, Motohiko Oshima, Koichi Murakami, Seiya Imoto, Zi‐Kui Liu, Tomohiko Tamura
article en
6 citations

Abstract

Hematopoietic stem cells (HSCs) exhibit significant age-related phenotypic and functional alterations. Although single-cell technologies have elucidated age-related compositional changes, prospective identification of aging-associated HSC subsets has remained challenging. In this study, using clusterin (Clu)-green fluorescent protein (GFP) reporter mice, we demonstrated that Clu expression faithfully marks age-associated myeloid/platelet-biased HSCs throughout life. Clu-GFP expression clearly segregates a novel age-associated HSC subset that overlaps with but is distinct from those previously identified using antibodies against aging maker proteins or reporter systems of aged HSC signature genes. Clu-positive (Clu+) HSCs emerge as a minor population in the fetus and progressively expand with age. Clu+ HSCs display not only an increased propensity for myeloid/platelet-biased differentiation but also a unique behavior in the bone marrow, favoring self-renewal over differentiation into downstream progenitors. In contrast, Clu-negative (Clu-) HSCs exhibit lineage-balanced differentiation, which predominates in the HSC pool during development but becomes underrepresented as aging progresses. Both subsets maintain long-term self-renewal capabilities even in aged mice but contribute differently to hematopoiesis. The predominant expansion of Clu+ HSCs largely drives the age-related changes observed in the HSC pool. Conversely, Clu- HSCs preserve youthful functionality and molecular characteristics into old age. Consequently, progressive changes in the balance between Clu+ and Clu- HSC subsets account for HSC aging. Our findings establish Clu as a novel marker for identifying aging-associated changes in HSCs and provide a new approach that enables lifelong tracking of the HSC aging process.

BloodVol. 146(1)
St. Jude Children's Research Hospital (US), Kyushu University (JP), Chiba University (JP), Yokohama City University Medical Center (JP), University of Oxford (GB), Tokyo Medical University Hospital (JP), University of Tokyo Hospital (JP), MRC Weatherall Institute of Molecular Medicine (GB), MRC Human Immunology Unit (GB), Anglo-Norman Text Society (GB), The University of Tokyo (JP), Yokohama City University (JP)
Openalex Percentile: Top 3%
Clusterin in disease pathology
6.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.